(Q72688564)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

S A Curley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M S Roh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

J L Chase

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

D C Hohn

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 December 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Surgery

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

743-6; discussion 746-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

Clinical perspective of human colorectal cancer metastasis

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

Effective surgical adjuvant therapy for high-risk rectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

Hepatic arterial flow distribution with hepatic neoplasms: significance in infusion chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

Alternating Hepatic Intra-Arterial Floxuridine and Fluorouracil: A Less Toxic Regimen for Treatment of Liver Metastases From Colorectal Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980691-9

10.1016/S0002-9610(05)80691-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8273861%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference